ATE392208T1 - Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten - Google Patents

Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten

Info

Publication number
ATE392208T1
ATE392208T1 AT04754081T AT04754081T ATE392208T1 AT E392208 T1 ATE392208 T1 AT E392208T1 AT 04754081 T AT04754081 T AT 04754081T AT 04754081 T AT04754081 T AT 04754081T AT E392208 T1 ATE392208 T1 AT E392208T1
Authority
AT
Austria
Prior art keywords
compositions
prevention
cold
treatment
flu
Prior art date
Application number
AT04754081T
Other languages
English (en)
Inventor
Paul Rennie
La Harpe Shane De
Jayant Khanolkar
Michael Mcdonald
Richard Sutton
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE392208T1 publication Critical patent/ATE392208T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
    • D21H27/30—Multi-ply
    • D21H27/32—Multi-ply with materials applied between the sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04754081T 2003-06-06 2004-06-01 Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten ATE392208T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/456,465 US20040033260A1 (en) 1999-10-19 2003-06-06 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc

Publications (1)

Publication Number Publication Date
ATE392208T1 true ATE392208T1 (de) 2008-05-15

Family

ID=33551299

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04754081T ATE392208T1 (de) 2003-06-06 2004-06-01 Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten

Country Status (13)

Country Link
US (1) US20040033260A1 (de)
EP (1) EP1633376B1 (de)
JP (1) JP2006526026A (de)
CN (1) CN1802162A (de)
AT (1) ATE392208T1 (de)
AU (1) AU2004247082B2 (de)
BR (1) BRPI0411050A (de)
CA (1) CA2527365C (de)
DE (1) DE602004013146T2 (de)
ES (1) ES2303645T3 (de)
MX (1) MXPA05013214A (de)
PL (1) PL1633376T3 (de)
WO (1) WO2004110463A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
DE10065045A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
US6620405B2 (en) * 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
NL1022532C2 (nl) * 2003-01-30 2004-08-03 Pronovamedical B V Samenstelling voor de preventieve behandeling van koortsuitslag.
DE10318526A1 (de) * 2003-04-24 2004-11-11 Beiersdorf Ag Reinigungsemulsion mit hohem Fettgehalt
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2522365T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
GB0602325D0 (en) * 2006-02-06 2006-03-15 Remedy Res Ltd Virucidal compositions and uses
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
US8895282B2 (en) * 2008-03-20 2014-11-25 Tanomed Ab Use of a substance for manufacturing of a medicament for treatment of common cold
US20110305768A1 (en) * 2008-07-01 2011-12-15 The Johns Hopkins University Quick-dissolving oral thin film for targeted delivery of therapeutic agents
JP4980337B2 (ja) * 2008-12-19 2012-07-18 株式会社シガドライウィザース ウイルス不活性化薬剤およびその製造方法
CN101961321B (zh) * 2010-09-17 2012-03-28 山东司邦得制药有限公司 葡萄糖酸锌糖片制剂及其制备方法
AT13384U1 (de) * 2012-12-14 2013-11-15 Fritsch Florian Mag Nahrungsergänzungsmittel
EP3888629A1 (de) * 2020-03-31 2021-10-06 Dr. Kurt Wolff GmbH & Co. KG Zusammensetzung zur behandlung oder vorbeugung einer virusinfektion
CN113827614A (zh) * 2020-06-24 2021-12-24 厦门大学 制备药用混合物的方法、所得药用混合物及其医药用途
EP3973966A1 (de) * 2020-09-24 2022-03-30 Dr. Kurt Wolff GmbH & Co. KG Hydroxyapatitzusammensetzung zur behandlung und/oder vorbeugung einer virusinfektion
TR202019326A2 (tr) 2020-11-30 2021-04-21 Haci Murat Mertoglu Ph değeri̇ sayesi̇nde anti̇vi̇ral etki̇ gösteren burun solüsyonu
EP4079300A1 (de) * 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Antivirale zusammensetzung zur verabreichung in nase, mund oder hals

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767788A (en) * 1978-08-14 1988-08-30 Sterling Drug Inc. Glutaric acid virucidal processes and compositions
JPS572690A (en) * 1980-06-05 1982-01-08 Kyowa Hakko Kogyo Co Ltd Preparation of l-proline by fermentation method
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US4828912A (en) * 1981-07-20 1989-05-09 Kimberly-Clark Corporation Virucidal product having virucidal and/or germicidal properties
US4897304A (en) * 1981-07-20 1990-01-30 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
USRE33465E (en) * 1981-07-31 1990-11-27 Method for reducing the duration of the common cold
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
US4826683A (en) * 1987-01-09 1989-05-02 Bates Harry L Decongestant
GB8902300D0 (en) * 1989-02-02 1989-03-22 Bryce Smith Derek Antirhinoviral preparations
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
EP1007077B1 (de) * 1997-01-13 2009-10-07 Emory University Glutathion zur behandlung von influenzainfektionen
GB2306109B (en) * 1997-02-07 1997-09-24 John Wright A zinc containing composition as a common cold prophylactic
US5820853A (en) * 1997-03-27 1998-10-13 The Procter & Gamble Company Oral compositions forming a coacervate gel
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray

Also Published As

Publication number Publication date
PL1633376T3 (pl) 2008-10-31
US20040033260A1 (en) 2004-02-19
CN1802162A (zh) 2006-07-12
CA2527365A1 (en) 2004-12-23
EP1633376A1 (de) 2006-03-15
AU2004247082A1 (en) 2004-12-23
CA2527365C (en) 2009-06-30
WO2004110463A1 (en) 2004-12-23
JP2006526026A (ja) 2006-11-16
DE602004013146D1 (de) 2008-05-29
MXPA05013214A (es) 2006-03-17
AU2004247082B2 (en) 2008-04-24
DE602004013146T2 (de) 2009-07-02
BRPI0411050A (pt) 2006-07-11
ES2303645T3 (es) 2008-08-16
EP1633376B1 (de) 2008-04-16

Similar Documents

Publication Publication Date Title
ATE392208T1 (de) Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten
ATE416761T1 (de) Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund
MXPA04003796A (es) Tioacetamidas sustituidas.
EP1562897A4 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
BR9909730A (pt) Dihidropirimidinas
GB0129260D0 (en) Pharmaceutical compositions and their uses
ATE276749T1 (de) Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung
ATE337780T1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
DE60330485D1 (de) Zur behandlung von diabetes
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
HK1150153A1 (en) Use of pramipexole to treat amyotrophic lateral sclerosis
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
BG66080B1 (bg) Заместени тиоацетамиди
ATE228369T1 (de) Nervenschützende zusammensetzung zur prophylaxe und behandlung von nervös- und verhaltungsänderungen durch angstartigen zuständen oder depressionen, die acetyl-l- carnitin und hypericin enthalt
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
ATE554169T1 (de) Smad7-inhibitoren zur behandlung von krankheiten des zns
DE60141636D1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
DE60021113D1 (de) Albumin-bindende verbindungen die die nichtenzymatische glycosylierung verhindern und die zur behandlung von glycosylierungsbedingten erkrankungen verwendet werden können
DE60332044D1 (de) Zusammensetzungen zur vorbeugung und behandlung von erkältung und influenza-ähnlichen erscheinungen enthaltend ausgewählte mukadhäsive polymere
DE60236446D1 (de) Glutation vorlaeufer zur behandlung von neuropsychiatrisschen krankheiten
RS8504A (en) Novel cyclohexil sulphones
ATE204759T1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties